GUIDE THERAPEUTICS
Guide Therapeutics is a biotechnology company that solves the challenge of delivery of genetic therapies. The company patented technologies to test thousands of chemically distinct nanoparticles in vivo. This enables them to identify simple, scalable, and clinically relevant nanoparticles that target new cell types efficiently and safely. It pioneers new gene therapies by developing field-leading drug delivery vehicles. Guide Therapeutics is using a proprietary screening platform that performs thousands of drug delivery experiments directly in vivo, they identify nanoparticles that deliver DNA or RNA to cell types others cannot reach.
GUIDE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2018-01-01
Address:
Tucker, Georgia, United States
Country:
United States
Website Url:
http://www.guidetx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.86 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Contact Form 7 Google Google Cloud Pound Sterling Japanese Yen
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
GuideRx
GuideRx is solving the challenge of delivery of genetic therapies.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Investors List
GreatPoint Ventures
GreatPoint Ventures investment in Venture Round - Guide Therapeutics
Official Site Inspections
http://www.guidetx.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Guide Therapeutics"
Guide Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Guide Therapeutics is a biotechnology company that solves the challenge of delivery of genetic therapies. The company patented technologies to test thousands of chemically distinct nanoparticles in …See details»
Guide Therapeutics Company Profile 2024: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Guide Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
www.guidetx.com
Www.guidetx.comSee details»
Guide Therapeutics - VentureRadar
GuideTx is solving the challenge of delivery of genetic therapies. The company was acquired by Beam Therapeutics in 2021. VentureRadar Research / Company Website. Associated sectors: …See details»
Beam Therapeutics Announces Acquisition of Guide Therapeutics
Feb 23, 2021 GuideTx was spun out of Georgia Tech in 2018 and backed by Biomatics Capital, GreatPoint Ventures, and GV. ... Beam is a values-driven organization committed to its …See details»
Guide Therapeutics - VentureRadar
Similar Companies: ADARx Pharmaceuticals USA Privately Held ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and …See details»
GuideTX - Company Profile - Tracxn
Oct 21, 2024 GuideTX ranks 21st among 93 active competitors. 35 of its competitors are funded while 15 have exited. Overall, GuideTX and its competitors have raised over $1.43B in funding …See details»
Guide Therapeutics Overview | SignalHire Company Profile
Phone Number: 509-863-3501: Guide Therapeutics industries Biotech, Pharmaceuticals, Biotechnology: Headquarters LocationSee details»
Guide Therapeutics - Overview, News & Similar companies
View Guide Therapeutics (www.guidetx.com) location in Georgia, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Beam Therapeutics Announces Acquisition of Guide Therapeutics
Feb 23, 2021 GuideTx was spun out of Georgia Tech in 2018 and backed by Biomatics Capital, GreatPoint Ventures, and GV. ... Beam is a values-driven organization committed to its …See details»
Beam Therapeutics Announces Acquisition of Guide Therapeutics
Feb 23, 2021 GuideTx’s Proprietary LNP Screening Technology and Lipid Library Supports Expanded Targeting of Diverse Tissues for In Vivo Delivery of Gene Editing ... Beam is a …See details»
GuideTX - Raised $13.9M Funding from 3 investors - Tracxn
Nov 20, 2024 GuideTX has raised a total funding of $13.9M over 2 rounds from 3 investors. Investors include Google Ventures, GreatPoint Ventures and 1 other. Their latest funding …See details»
Guide Therapeutics - Devex
Learn more about Guide Therapeutics's jobs, projects, latest news, contact information and geographical presence. Guide Therapeutics, Inc. has patented technologies to test thousands …See details»
大手笔，张锋/刘如谦创立的单碱基编辑公司Beam，斥资4.4亿美元 …
Feb 26, 2021 GuideTx 的优势在于，其拥有专利的 LNP筛选技术可通过 DNA条形码标记纳米颗粒，从而可以在一个实验中对单个动物筛选数百个纳米颗粒，这可以帮助减少评估纳米颗粒在动 …See details»
Beam Completes Acquisition of GuideTx - Global Genes
Feb 23, 2021 Using this platform, GuideTx has identified a broad library of lipids and lipid formulations that could accelerate novel delivery of gene editing payloads to tissues beyond …See details»
Beam Therapeutics Announces Acquisition of Guide
Feb 23, 2021 GuideTx was spun out of Georgia Tech in 2018 and backed by Biomatics Capital, GreatPoint Ventures, and GV. ... Beam is a values-driven organization committed to its …See details»
Beam Therapeutics Acquires Guide Therapeutics | citybiz
Feb 23, 2021 Using this platform, GuideTx has identified a broad library of lipids and lipid formulations that could accelerate novel delivery of gene editing payloads to tissues beyond …See details»
Beam Therapeutics Announces Acquisition of Guide Therapeutics
Feb 23, 2021 GuideTx’s Proprietary LNP Screening Technology and Lipid Library Supports Expanded Targeting of Diverse Tissues for In Vivo Delivery of Gene Editing. CAMBRIDGE, …See details»
Beam Therapeutics’ $120 Million Acquisition of GuideTx
Mar 3, 2021 Orrick Herrington & Sutcliffe LLP advised Guide Therapeutics on the deal.Guide Therapeutics (GuideTx), a developer of nonviral drug delivery vehicles for genetic medicines, …See details»
Beam Therapeutics Announces Acquisition of Guide Therapeutics
Feb 24, 2021 Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. ...See details»